SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-268094
Filing Date
2019-10-16
Accepted
2019-10-16 08:53:41
Documents
6
Period of Report
2019-10-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d806799d8k.htm 8-K 53324
2 EX-2.1 d806799dex21.htm EX-2.1 618068
3 EX-3.1 d806799dex31.htm EX-3.1 4520
4 EX-99.1 d806799dex991.htm EX-99.1 28056
5 GRAPHIC g806799g1016070932706.jpg GRAPHIC 2425
6 GRAPHIC g806799g1016070932878.jpg GRAPHIC 2178
  Complete submission text file 0001193125-19-268094.txt   711848
Mailing Address 300 GEORGE STREET NEW HAVEN CT 06511
Business Address 300 GEORGE STREET NEW HAVEN CT 06511 203-624-7000
ACHILLION PHARMACEUTICALS INC (Filer) CIK: 0001070336 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33095 | Film No.: 191152009
SIC: 2834 Pharmaceutical Preparations